Birgit Geoerger
Villejuif, 94805, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 162 publications
Erdafitinib in Patients With Advanced Solid Tumors With FGFR Alterations (RAGNAR): Results of Tumor-Specific Analyses and Secondary Cohorts.
Journal: JCO precision oncology
Published: July 15, 2026
Eligibility criteria in pediatric oncology phase I and II clinical trials: Analysis and recommendations for standardization from the Innovative Therapies for Children and Adolescents with Cancer (ITCC) Consortium.
Journal: European journal of cancer (Oxford, England : 1990)
Published: March 23, 2026
Paediatric Therapeutic Development Workshop on rhabdomyosarcoma.
Journal: British journal of cancer
Published: February 04, 2026
Co-targeting CDK4/6 and MEK reverses mesenchymal transition in therapy-refractory BRAF-altered pediatric high-grade glioma.
Journal: Journal of experimental & clinical cancer research : CR
Published: January 28, 2026
Dabrafenib in pediatric patients with BRAF V600 mutation-positive high-grade glioma: Results from a phase 1/2a single-arm study.
Journal: Neuro-oncology practice
Published: December 29, 2025
Phase I/II Study of the CDK2/9 Inhibitor Fadraciclib in Combination with Chemotherapy in Children with Advanced Malignancies: Arm K of the AcSé-ESMART Trial.
Journal: Targeted oncology
Published: November 24, 2025
The ITCC-P4 PDX Platform Enables Preclinical Testing of Pediatric Cancers.
Journal: Cancer research
Published: November 19, 2025
First-year results of the International Leukemia/Lymphoma Target Board for pediatric relapsed and refractory hematological malignancies.
Journal: Haematologica
Published: November 04, 2025
Phase I/II Study of the PARP Inhibitor Olaparib and Irinotecan in Children and Young Adults with Recurrent/Refractory Malignancies: Arm D of the AcSé-ESMART Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 08, 2025
Ex vivo drug sensitivity profiling to complement molecular profiling in pediatric precision oncology.
Journal: NPJ precision oncology
Published: July 23, 2025
Ex vivo drug sensitivity profiling to complement molecular profiling in pediatric precision oncology.
Journal: NPJ precision oncology
Published: July 23, 2025
Fighting sarcomas at the root: The role of mesenchymal stem cells in sarcomagenesis.
Journal: European journal of cancer (Oxford, England : 1990)
Published: June 06, 2025
Last Updated: 09/26/2026